Beruflich Dokumente
Kultur Dokumente
(https://bestpractice.bmj.com/login)
Bene ts
(https://bestpractice.bm
What is GRADE? features/)
The authors then rate the quality of evidence, which is best applied to each outcome, because the
quality of evidence o en varies between outcomes.[5] An overall GRADE quality rating can be
applied to a body of evidence across outcomes, usually by taking the lowest quality of evidence
from all of the outcomes that are critical to decision making.[6]
GRADE has four levels of evidence – also known as certainty in evidence or quality of evidence:
very low, low, moderate, and high (Table 1). Evidence from randomised controlled trials starts at
high quality and, because of residual confounding, evidence that includes observational data starts
at low quality. The certainty in the evidence is increased or decreased for several reasons,
described in more detail below.
Very low The true e ect is probably markedly di erent from the estimated e ect
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 1/8
10/23/2019 What is GRADE? | BMJ Best Practice
Low The true e ect might be markedly di erent from the estimated e ect
Moderate The authors believe that the true e ect is probably close to the estimated e ect
High The authors have a lot of con dence that the true e ect is similar to the estimated e ect
GRADE is subjective
GRADE cannot be implemented mechanically – there is by necessity a considerable amount of
subjectivity in each decision. Two persons evaluating the same body of evidence might reasonably
come to di erent conclusions about its certainty. What GRADE does provide is a reproducible and
transparent framework for grading certainty in evidence.[7]
1. Risk of bias
Bias occurs when the results of a study do not represent the truth because of inherent limitations
in design or conduct of a study.[8] In practice, it is di cult to know to what degree potential biases
in uence the results and therefore certainty is lower in the estimated e ect if the studies
informing the estimated e ect could be biased.
There are several tools available to rate the risk of bias in individual randomised trials[9] and
observational studies.[10, 11]
GRADE is used to rate the body of evidence at the outcome level rather than the study level.
Authors must therefore make a judgement about whether the risk of bias in the individual studies
is su ciently large that their con dence in the estimated treatment e ect is lower. Key
considerations for risk of bias and a detailed description of the process for moving from risk of bias
at the study level to risk of bias for a body of evidence is described in detail in the GRADE
guidelines series #4: Rating the quality of evidence – study limitations (risk of bias).[8]
2. Imprecision
The GRADE approach to rating imprecision focuses on the 95% con dence interval around the
best estimate of the absolute e ect.[12] Certainty is lower if the clinical decision is likely to be
di erent if the true e ect was at the upper versus the lower end of the con dence interval.
Authors may also choose to rate down for imprecision if the e ect estimate comes from only one
or two small studies or if there were few events.[13] A detailed description of imprecision is
described in the GRADE guidelines series #6: Rating the quality of evidence – imprecision.[12]
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 2/8
10/23/2019 What is GRADE? | BMJ Best Practice
3. Inconsistency
Certainty in a body of evidence is highest when there are several studies that show consistent
e ects. When considering whether or not certainty should be rated down for inconsistency,
authors should inspect the similarity of point estimates and the overlap of their con dence
intervals, as well as statistical criteria for heterogeneity (e.g., the I2 and chi-squared test).[14] A full
discussion of inconsistency is available in the GRADE guidelines series #7: rating the quality of
evidence – inconsistency.[14]
4. Indirectness
Evidence is most certain when studies directly compare the interventions of interest in the
population of interest, and report the outcome(s) critical for decision-making. Certainty can be
rated down if the patients studied are di erent from those for whom the recommendation applies.
Indirectness can also occur when the interventions studied are di erent than the real outcomes
(for example, a study of a new surgical procedure in a highly specialized centre only indirectly
applies to centres with less experience). Indirectness also occurs when the outcome studied is a
surrogate for a di erent outcome – typically one that is more important to patients. A full
discussion of indirectness is available in the GRADE guidelines series #8: rating the quality of
evidence – indirectness.[15]
5. Publication bias
Publication bias is perhaps the most vexing of the GRADE domains, because it requires making
inferences about missing evidence. Several statistical and visual methods are helpful in detecting
publication bias, despite having serious limitations. Publication bias is more common with
observational data and when most of the published studies are funded by industry. A full
discussion of publication bias is available in the GRADE guidelines series #5: rating the quality of
evidence – publication bias.[16]
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 3/8
10/23/2019 What is GRADE? | BMJ Best Practice
• Risk of bias
• Large magnitude of e ect
• Imprecision
• Dose-response gradient
• Inconsistency
• All residual confounding would decrease magnitude of e ect (in
• Indirectness
situations with an e ect)
• Publication bias
Recommendations are more likely to be weak rather than strong when the certainty in evidence is
low, when there is a close balance between desirable and undesirable consequences, when there
is substantial variation or uncertainty in patient values and preferences, and when interventions
require considerable resources. A full discussion is available in the BMJ series on the GRADE
Evidence to Decision framework[18, 19] and in the original series[2, 20].
References
1. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of
evidence” and why is it important to clinicians? BMJ (Clinical research ed). 2008;336(7651):995-
8.
2. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging
consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical
research ed). 2008;336(7650):924-6.
3. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-
GRADE evidence pro les and summary of ndings tables. Journal of clinical epidemiology.
2011;64(4):383-94.
4. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the
question and deciding on important outcomes. Journal of clinical epidemiology.
2011;64(4):395-400.
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 4/8
10/23/2019 What is GRADE? | BMJ Best Practice
5. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3.
Rating the quality of evidence. Journal of clinical epidemiology. 2011;64(4):401-6.
6. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, et al. GRADE guidelines: 11.
Making an overall rating of con dence in e ect estimates for a single outcome and for all
outcomes. Journal of clinical epidemiology. 2013;66(2):151-7.
7. Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is
reproducible in assessing the quality of evidence of quantitative evidence syntheses. Journal of
clinical epidemiology. 2013;66(7):736-42; quiz 42.e1-5.
8. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating
the quality of evidence–study limitations (risk of bias). Journal of clinical epidemiology.
2011;64(4):407-15.
9. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane
Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed).
2011;343:d5928.
10. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale
(NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa
Hospital Research Institute; 2011. oxford. asp; 2011.
11. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool
for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical research ed).
2016;355:i4919.
12. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6.
Rating the quality of evidence–imprecision. Journal of clinical epidemiology. 2011;64(12):1283-
93.
13. Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, et al. The statistical
signi cance of randomized controlled trial results is frequently fragile: a case for a Fragility Index.
Journal of clinical epidemiology. 2014;67(6):622-8.
14. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7.
Rating the quality of evidence–inconsistency. Journal of clinical epidemiology.
2011;64(12):1294-302.
15. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8.
Rating the quality of evidence–indirectness. Journal of clinical epidemiology. 2011;64(12):1303-
10.
16. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the
quality of evidence–publication bias. Journal of clinical epidemiology. 2011;64(12):1277-82.
17. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9.
Rating up the quality of evidence. Journal of clinical epidemiology. 2011;64(12):1311-6.
18. Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al.
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 5/8
10/23/2019 What is GRADE? | BMJ Best Practice
making well informed healthcare choices. 1: Introduction. BMJ (Clinical research ed).
2016;353:i2016.
19. Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE
Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well
informed healthcare choices. 2: Clinical practice guidelines. BMJ (Clinical research ed).
2016;353:i2089.
20. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to
recommendations. BMJ (Clinical research ed). 2008;336(7652):1049-51.
Learn EBM
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 6/8
10/23/2019 What is GRADE? | BMJ Best Practice
Helpful Links
Legal (https://bestpractice.bmj.com/info/legal/) Privacy
(https://bestpractice.bmj.com/info/privacy/)
Site map
(https://bestpractice.bmj.com/info/site-map/) Contact us
(https://bestpractice.bmj.com/info/contact-us-
3/)
Connect with us
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 7/8
10/23/2019 What is GRADE? | BMJ Best Practice
(https://twitter.com/BMJBestPractice)
(https://www.facebook.com/BMJBestPractice)
(https://www.youtube.com/user/BMJCompany)
(https://bestpractice.bmj.com/info/rss-feeds/)
© BMJ Publishing Group Limited 2019. All rights reserved. | Back to top
https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/ 8/8